Approval · Notice of Compliance 11994 · 2011
RAPAFLO: Notice of Compliance 11994
Issued January 11, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11994
- Date
- January 11, 2011
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective antagonist for alpha1A adrenoreceptor subtype in the prostate and bladder